title: Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: a retrospective study.
authors.affiliation: Department of Hematology, University Hospital Lund, Lund University, Lund, Sweden. vladimir.lazarevic@skane.se
authors.forename: Vladimir Lj
authors.initials: VLj
authors.lastname: Lazarevic
authors.forename: Mats
authors.initials: M
authors.lastname: Remberger
authors.forename: Hans
authors.initials: H
authors.lastname: Hägglund
authors.forename: Helene
authors.initials: H
authors.lastname: Hallböök
authors.forename: Gunnar
authors.initials: G
authors.lastname: Juliusson
authors.forename: Eva
authors.initials: E
authors.lastname: Kimby
authors.forename: Claes
authors.initials: C
authors.lastname: Malm
authors.forename: Anders
authors.initials: A
authors.lastname: Wahlin
authors.forename: Hamdy
authors.initials: H
authors.lastname: Omar
authors.forename: Jan-Erik
authors.initials: JE
authors.lastname: Johansson
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D005260:Female; D006086:Graft vs Host Disease / Q000453:epidemiology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D019653:Myeloablative Agonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D012008:Recurrence; D012189:Retrospective Studies; D016019:Survival Analysis; D013548:Sweden / Q000453:epidemiology; D013997:Time Factors; D014184:Transplantation, Homologous; D055815:Young Adult
chemical_list: D019653:Myeloablative Agonists